Login / Signup

Combination therapy with immune check point inhibitors and acute kidney injury.

Amalie ValentinAnne Kirstine Hundahl MøllerJesper Andreas PalshofBo BrobergEva GravesenInge Marie SvaneDitte Hansen
Published in: Acta oncologica (Stockholm, Sweden) (2023)
Patients receiving combination therapy with checkpoint inhibitors are at high risk of AKI, but different causes of AKI should always be considered. Use of PPI concurrently with ICIs is likely to increase the risk of AKI.
Keyphrases
  • combination therapy
  • acute kidney injury
  • cardiac surgery
  • dna damage
  • cell cycle
  • protein protein
  • oxidative stress
  • small molecule